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MelanocytesNeural crest cells (NCCs) are a transient embryonic structure that gives rise to a variety of cells including
peripheral nervous system, melanocytes, and Schwann cells. To understand the molecular mechanisms
underlying NCC development, a gene manipulation of NCCs by in ovo electroporation technique is a powerful
tool, particularly in chicken embryos, the model animal that has long been used for the NCC research.
However, since expression of introduced genes by the conventional electroporation method is transient, the
mechanisms of late development of NCCs remain unexplored. We here report novel methods by which late-
developing NCCs are successfully manipulated with electroporated genes. Introduced genes can be stably and/
or conditionally expressed in a NCC-speciﬁc manner by combining 4 different techniques: Tol2 transposon-
mediated genomic integration (Sato et al., 2007), a NCC-speciﬁc enhancer of the Sox10 gene (identiﬁed in this
study), Cre/loxP system, and tet-on inducible expression (Watanabe et al., 2007). This is the ﬁrst
demonstration that late-developing NCCs in chickens are gene-manipulated speciﬁcally and conditionally.
These methods have further allowed us to obtain ex vivo live-images of individual Schwann cells that are
associated in axon bundles in peripheral tissues. Cellular activity and morphology dynamically change as
development proceeds. This study has opened a new way to understand at the molecular and cellular levels
how late NCCs develop in association with other tissues during embryogenesis.ical Sciences, Nara Institute of
ra, 630–0192, Japan. Fax: +81
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During vertebrate development, the neural crest (NC) is a
transient structure that gives rise to a variety of tissues, including
all types of peripheral nervous system in the trunk. Neural crest cells
(NCCs) emigrate from the dorsal aspect of the neural tube, and
migrate over distances in the body to their destinations, where they
undergo terminal differentiation (Le Douarin and Kalcheim, 1999). An
increasing body of knowledge accumulates regarding the molecular
mechanisms by which neural crest speciﬁcation and early emigration
are regulated (Knecht and Bronner-Fraser, 2002; Meulemans and
Bronner-Fraser, 2004). For these studies, a gene manipulation
technique serves as a powerful tool. In particular, in chicken embryos
that have long been used as a most suitable model animal for the NC
study, the in ovo electroporation technique (Funahashi et al., 1999;
Momose et al., 1999) has enabled NCC transgenesis (Harris et al.,
2008; McKeown et al., 2005; Petiot et al., 2002; Tucker, 2001). In most
cases for the NC-transgenesis, exogenous genes are introduced into an
early neural tube, from which NCCs emigrate carrying these genes.However, the usefulness of the electroporation technique has been
limited to earlier events of NCCs: since electroporated genes are not
integrated into the genome, their copies become diluted and ultimately
disappear as NCCs undergo massive proliferation. Thus, the molecular
mechanisms underlying later development of NCC-derived lineages
remain largely unexplored. During late stages in the trunk, a variety of
important events occur in NCC-derivatives: melanocytes, sensory
neurons, Schwann cells and others undergo terminal differentiation
and start exhibiting their characteristics of physiological functions. For
instance, Schwann cells, the precursor of myelin sheaths, become
intimately associated with axons in peripheral tissues.
Toward understanding the molecular mechanisms underlying the
late development of NCCs, we have in this study developed novel gene
manipulation methods that offer three major advantages; long-term
expression, NCC-speciﬁc expression, and conditionally inducible ex-
pression. First, long-term expression is achieved by the Tol2-mediated
genomic integrationmethod,whichwe recently established (Sato et al.,
2007). Second, NCC-speciﬁc expression is enabled by a NCC-speciﬁc
enhancer of Sox 10 gene, identiﬁed in this study. Further combination
with Cre/loxP system (Gu et al., 1994; Hamilton and Abremski, 1984;
Lobe et al., 1999; Nagy, 2000) allows NCC-speciﬁc and long-term
expression of introduced EGFP. Third, the tetracycline-dependent
expression system (tet-on; Watanabe, et al., 2007; Sato, et al., 2007) is
applied to conditionally express exogenous genes at adesired timepoint
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neurons, Schwann cells, and melanocytes in peripheral tissues to be
EGFP-labeled in a genetically manipulable manner. Furthermore, we
have performed live-imaging microscopy to directly visualize EGFP-
labeled Schwann cells using ex vivo cultured tissues. These cells actively
extend and retract cellular processes prior to cellular elongation along
peripheral axon bundles. Thus, this study has opened a new way to
understand at the molecular and cellular levels how late NCCs develop
in association with neighboring tissues during embryogenesis.
Materials and methods
Embryological manipulations
Commercially available chicken eggs were delivered from poultry
farm, and basic techniques and electroporation were as previously
described (Sato et al., 2002). A DNA solution was injected into the
central canal of the neural tube of E2 embryo. Electric pulses of 12 V,
25 ms were charged ﬁve times with 975-ms intervals.
Genomic clones of chicken Sox10 locus
Genomic fragments in a 5′ UTR region of Sox10ORFwere ampliﬁed
with KOD-Plus-ver.2 (TOYOBO), using BAC DNA clones as the
template (CH261-72C6, BACPAC Resources; Tam33-18P11, GENEﬁn-
der Genomic Resources, Texas A&M University). Each fragment,
ranging from 0.6 kb to 10 kb in size, was cloned into either SalI, BglII,
XhoI, or SmaI site of ptkEGFP vector. The ptkEGFP reporter vector (gift
from Dr. Kondoh, Osaka University) possesses Herpes simplex virus
thymidine kinase basic promoter (tk) upstream of EGFP (Uchikawa et
al., 2003). Successful subcloning for each genomic fragment was
veriﬁed by partial sequencing of the terminal region.
Vector constructions
pT2K-CAGGS-EGFP, pCAGGS-T2TP, and pT2K-BI-TRE-EGFP
These constructs were previously described in Sato et al., 2007.
pCAGGS-mCherry and pT2K-CAGGS-mCherry
mCherry cDNA (Clontech) was subcloned into the XhoI site of
pCAGGS (Momose et al., 1999) to make pCAGGS-mCherry, from which
mCherry was digested with EcoRI-EcoRV, and subcloned into the same
sites of pT2K-CAGGS (Sato et al., 2007) tomake pT2K-CAGGS-mCherry.
pT2K-enhancer4-1-tkEGFP
pEnhancer4-1-tkEGFP was digested with KpnI–SpeI to obtain the
fragment containing enhancer4-1 and tkEGFP, which was subsequently
subcloned into ApaI–BglII site of pT2K-BI-TRE-EGFP after blunt ended.
pCAGGS-Cre
This is the same as pxCANCre, which was originally reported in
Kanegae et al. (1996). In this study,wedescribepxCANCre (pCAGGS-Cre).
pEnhancer4-1-tk-Cre
pEnhancer4-1-tk-Cre is a derivative of pEnhancer4-1-tkEGFP. First,
ptk-Cre was constructed: the cDNA fragment encoding nuclear
localizing signal (NLS)-fused Cre (Kanegae et al., 1996) was subcloned
into ptkEGFP at the site of StyI and NdeI, in between tk and SV40-
ployA to replace EGFP. Subsequently, enhancer4-1 (SalI-sited) was
inserted into SalI-digested ptk-Cre.
pT2K-CAGGS-loxP-DsRed2-loxP-EGFP
pCALNL5 (Kanegae et al., 1996) was manufactured so that the
DsRed2-polyA fragment was inserted in between loxP sites of the
plasmid. Subsequently, SmaI-sited EGFP was added after the second
loxP. From this construct, a fragment spanning from the ﬁrst loxP toEGFP was PCR-ampliﬁed, and inserted into the EcoRV site positioned
between CAGGS and polyA of pT2K-CAGGS, to make the ﬁnal
construct of pT2K-CAGGS-loxP-DsRed2-loxP-EGFP.
pT2K-CAGGS-loxP-DsRed2-loxP-rtTA2S-M2
The procedure was as described above (pT2K-CAGGS-loxP-
DsRed2-loxP-EGFP) with rtTA2S-M2 in place of EGFP. rtTA2s-M2 is a
kind gift of Dr. Hillen (Urlinger et al., 2000; Watanabe et al., 2007).
Comparative genomic analyses
Highly conserved genomic sequences between different species
were searched by VISTA (http://pipeline.lbl.gov/cgi-bin/gateway2)
(Mayor et al., 2000). Conserved genomic sequences with no lower
than 60% identity continuing over 100 bp were selected.
DNA transfection with DF1 cells
The basic protocol was as described in Sato et al., 2007. DF1, an
avian cell line purchased from ATCC (Himly et al., 1998), was
maintained in Dulbecco's Modiﬁed Eagle's Medium containing 10%
fetal bovine serum. 5×105 DF1 cells were plated and subjected to DNA
transfection on the following day using Lipofectamine 2000 (Invitro-
gen) with DNA plasmids, the total amount of which not exceeding
4 μg (500 ng of pT2K-CAGGS-loxP-DsRed2-loxP-EGFP, pT2K-CAGGS-
loxP-DsRed2-loxP-rtTA2S-M2, pT2K-BI-TRE-EGFP, and pCAGGS-T2TP,
0.1 ng to 50 ng of pxCANCre). EGFP and DsRed2 signals were detected
using AxioPlanII microscope with Apotome system (Carl Zeiss), or
LSM5 PASCAL confocal laser scanning microscope (Carl Zeiss).
Administration of a doxycycline (Dox) solution
For developing embryos, as previously described (Watanabe et al.,
2007), 500 μl of Dox solution (0.3 mg/ml in HANKS: 140 mM NaCl,
5.4 mMKCl, 5.6 mM glucose, 0.34 mMNa2HPO4, 10 mMHEPES, 1 mM
MgCl2, 1 mM CaCl2 pH 7.0) was injected in between the embryo and
yolk. For cultured DF1 cells, the Dox solution was added to the culture
medium at the concentration of 1 μg/ml was added.
Western blotting
DF1 cells were treated with 4× sodium dodecyl sulfate (SDS)
sample buffer (200 mM Tris–HCl, (pH 6.8), 8% SDS, 400 mM
dithiothreitol, 0.2% bromophenol blue, 40% glycerol). The eluates
were subjected to SDS-PAGE followed by immunoblottingwithmouse
anti-GFP monoclonal antibody (Santa Cruz), and HRP-conjugated
sheep anti-mouse IgG antibody (Amersham). Signals for EGFP protein
were revealed with the ECL Advance Western Blotting Detection kit
(Amersham). Densitometric analysis was performed using the
luminous image analyzer LAS-3000 mini (Fuji Film).
Immunohistochemistry
Immunohistochemistry with frozen sections was performed essen-
tially as previously described (Sato et al., 2002; Watanabe et al., 2007).
Embryoswereﬁxed in4%paraformaldehyde(PFA) at4 °Covernight and
immersed in a graded series of sucrose solutions up to 30%, then
embedded in Tissue-Tek (Sakura). 10 μmcryostat sectionswere treated
with 2% skimmilk/PBS for 1 h at room temperature (RT), and incubated
overnight at 4 °C in 1:500 dilution of HNK-1 antibody (Bio-Rad). After
washing three times in PBS, the specimenswere reactedwith Alexa 568
goat anti-mouse IgM (Molecular Probes) with 1:500 dilution for 1 h at
RT. The reactionwas terminated bywashing three times in PBS, and the
sections were sealed by Fluoromount (Diagnostic BioSystems).
For immunohistochemistry with a ﬂat-mount specimen, a surface
tissue, mostly containing epidermis, was peeled from a ﬂank region of
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detection of sensory neurons and melanocytes, the tissue was treated
with 2% skimmilk/PBS for 1 h at RT, and incubated overnight at 4 °C in
1:300 dilution of anti-Tuj1 antibody (R&D Systems), or in 1:100
dilution of anti-MITF antibody (Invitrogen). After washing three times
in PBS, the specimens were reacted with Alexa 568 goat anti-mouse
IgG with 1:500 dilution for 1 h at RT. The reaction was terminated by
washing three times in PBS, followed by mounting in a slide glass as a
ﬂat specimen. For the detection of Schwann cells, ﬁxed surface tissues
were treated in TNB (0.1 M Tris–HCl pH7.5, 0.15 M NaCl, 0.05% Tween
20, Blocking Reagent (Roche)) for 1 h at RT, and incubated overnight
at 4 °C in 1:300 dilution of anti-P0 antibody (1E8, Developmental
Studies Hybridoma Bank). After washing three times in TNT(0.1 M
Tris–HCl pH7.5, 0.15 M NaCl, 0.05% Tween 20), the specimens were
reacted with Alexa 568 goat anti-mouse IgG with 1:500 dilution for
1 h at RT. The reaction was terminated by washing three times in TNT.
EGFP signals and immunoﬂuorescencewere obtained using AxioPlanII
microscope with Apotome system (Carl Zeiss).
In situ hybridization with Sox10 probe in histological sections
Chicken Sox 10 cDNA was obtained by RT-PCR using the following
primers: 5′-AATTCTCGAGATGGCTGATGACCAAGATCT-3′ (forward),
and 5′-AATTGATATCCTATGGTCTGGAGAGAGTCG-3′ (reverse). Prepa-
ration of a digoxigenin-labeled probe, and section in situ hybridiza-
tion was as previously described (Sato et al., 2002).
Ex vivo culture of sliced specimens and live-imaging microscopy
Ex vivo slice culture was performed as previously reported (Ohata
et al., 2009) with some modiﬁcations. The “basic medium” was
prepared with DMEM/Ham's F12 (Wako), 25 mM sodium bicarbon-
ate, 15 mM HEPES, 50 IU/ml penicillin, and 50 mg/ml streptomycin.
For a sample mounting, 1% low-melting-point agarose (Invitrogen) in
DMEM/Ham's F12 medium, containing 1 mM sodium pyruvate, 5 mM
glutamine, and 5 mg/ml fungizone, was prepared. Transverse slices of
embryos of ~400 μm thick were prepared in the basic medium at RT
using a sharpened microsurgical blade (FEATHER). The slices were
mounted in a small volume of 1% agarose medium prepared in a
35 mm glass-bottom dish (MATSUNAMI). 10 min after mounting, the
dish was ﬁlled with the culture medium. The specimens were placed
in an incubation chamber connected to a LSM5 Pascal confocal laser
scanning microscope (Carl Zeiss). Images were obtained and
processed with LSM Image Browser software (Carl Zeiss).
Results and discussion
Stable transgenesis of NCCs by Tol2-mediated gene transfer
To stably introduce exogenous genes into NCCs, we combined the in
ovoelectroporation techniquewith theTol2-transposon-mediated gene
transfer method, which we previously optimized for somitic manipula-
tion in chicken embryos (Sato et al., 2007). As described in that report,
three kinds of plasmids were used (Fig. 1A): pCAGGS-T2TP (a plasmid
containing a constitutive promoter (CAGGS) that drives cDNA encoding
the transposase (T2TP) required for genomic integration), pT2K-
CAGGS-EGFP (pT2K-vector carries Tol2-sequences necessary for ge-
nomic integration), and pCAGGS-mCherry (the plasmid used for short
term monitoring of electroporation efﬁciency). These three plasmids
were co-electroporated into early neural tube/neural crest at embryonic
day 2 (E2). At E3 when a neural crest population started emigrating,
both EGFP and mCherry signals were successfully observed in an
overlapping set of cells (Fig. 1B, n=26). In contrast, at E7 (5-day post
electroporation), whereas mCherry signal (non-integrated) was hardly
detected in dorsal root ganglion (DRG) probably due to a massive cell
division of NCCs, EGFP signals were retained in these cells (Fig. 1C,n=11). This was also quantitatively conﬁrmed: the ratio of EGFP+ cells
over mCherry+ cells increased as development proceeded (1.1±0.2 at
E3 to 5.7±2.0 at E7, Fig. 1D). Thus, the Tol2-mediated gene transfer
technique enables NCCs to be stably manipulated with electroporated
genes. In contrast to NCCs, a signiﬁcant number of cells remained
mCherry-positive in the spinal cord (Fig. 1C). This is probably because
precociously differentiated neurons that no longer undergo cell
proliferation could harbor genomically non-integrated plasmids.
NCCs are known to give rise to a variety of cell types including
sensory neurons, Schwann cells, and melanocytes. Indeed, we
observed EGFP signals in these lineages at E7 (n=7, Fig. 1E–G).
Each cell type was conﬁrmed by immuno-cytochemistry with
antibodies against Tuj1, P0, and MITF, respectively, in a ﬂat-mounted
surface tissue peeled from the ﬂank region of E7 embryos (Fig. 1).
NCC-speciﬁc manipulation using Sox10 enhancer
The gene manipulation described in Fig. 1 also caused stable
expression of EGFP in motor neurons located in the ventral region of
the spinal cord (Fig. 1C), from which motor axons are extended into
peripheral tissues. Since motor axons are ensheathed by Schwann
cells and also often accompanied with sensory neurons, it would be
useful if NCCs could speciﬁcally be manipulated separately from
motor neurons. To achieve this, we attempted to identify a NCC-
speciﬁc enhancer of the Sox10 gene, a member of SRY-box family,
known to be speciﬁcally expressed in early NCCs (Betters et al., 2010;
Cheng et al., 2000; Southard-Smith et al., 1998). We conﬁrmed the
NCC-speciﬁc expression of Sox10 mRNA by comparing with HNK-1
signals, another NCC marker, in neighboring sections (Fig. 2A).
To identify a Sox10 enhancer(s), we performed in silico genomic
comparison that ﬁnds highly conserved non-coding elements (CNE)
between different species. Genomic sequences spanning ~43 kb
including the chicken Sox10 open reading frame (ORF)were compared
with the human genome using VISTA application (http://pipeline.lbl.
gov/cgi-bin/gateway2). Sevendifferent CNEs showing N60%homology
within 100 bp were selected, among which ﬁve (red peaks) and two
(light blue peaks, UTRs) were in the 5′- and 3′ regions of the Sox10
gene, respectively (Fig. 2B, Table 1). For subsequent analyses, 8 over-
lapping genomic regions (#1–#8, Fig. 2B), containing zero to two of
these CNEs, were obtained using chicken BAC clones that included
Sox10 genomic sequences. These 8 fragments and their further
dissected fragments were individually inserted into the EGFP reporter
plasmid, ptkEGFP (Fig. 2C) (Uchikawa et al., 2003), carrying the
thymidine kinase (tk) basal promoter and EGFP. Thus, this reporter
would express EFGP only when receiving an appropriated enhancer.
ptkEGFP inserted with each of 20 different candidate enhancers was
co-electroporated with pCAGGS-mCherry into the neural tube of E2
embryo (Fig. 2C), and EGFP signalwas assessed inmigratingNCCs of E2.5
embryo. Such analyses identiﬁed three types of CNEs in regard to EGFP
expression. First one was the expression speciﬁc to NCCs (blue boxes,
including #4-1). The second was the expression seen in both NCCs and
neural tube (gray boxes including #1-4), and the third showed no
expression (white boxes) (Fig. 2B, Table 2. Fig. 2D shows two
representative specimens: whole-mount- and transverse views of
embryos electroporated with ptkEGFP-#1-4 (EGFP in neural tube and
NCCs, n=10) and ptkEGFP-#4-1 (EGFP speciﬁcally in NCCs, n=10). The
speciﬁc expression by #4-1 was also conﬁrmed quantitatively: a ratio of
the number of EGFP+ cells over mCherry+ cells in the neural tube was
0.054±0.037 for ptkEGFP-#4-1,whereas 0.77±0.161 for ptkEGFP-#1-4
(Fig. 2E). Importantly, EGFP+ cells found in ptkEGFP-#4-1-electropo-
rated embryos overlapped with endogenous Sox10mRNA-positive cells
(Fig. 2D, n=10). Together,we conclude that the fragment#4-1 (3571 bp
long, the position −10,762 bp to −7192 bp), which contains CNE #3,
acts as a NCC-speciﬁc enhancer of Sox10 at least in early migrating NCCs.
We hereafter refer this region #4-1 to enhancer4-1. Enhancer4-1, thus
identiﬁed in this study independently, is found to overlap with an
Fig. 1. Stable transgenesis of NCCs by Tol2-mediated gene transfer. (A) Three plasmids were co-electroporated into a neural tube of E2 embryo. (B, C) At E3, both EGFP- and mCherry
signals were observed in the spinal cord (Sp) and developing DRG (arrows). By E7, although mCherry signal (not integrated) was extinguished, EGFP signal (integrated) was
retained. Scale bar: 100 μm. (D) Retained expression of EGFP was quantitatively demonstrated by a ratio of the number of EGFP-positive cells over mCherry-positive cells in DRG.
n=12 for E3, n=9 for E7. (E–G) EGFP signal was stably expressed in late-developing NCC-derived cells (arrowheads). A surface tissue including skin was peeled from the ﬂank
region of electroporated E7 embryo as shown in a diagram, and subjected to a preparation of ﬂat-mount specimen. Sensory neurons, stained with Tuj1 (E), Schwann cells associated
with peripheral axons, stained with P0 (F), and melanocytes in the skin, stained with MITF (G). Scale bar: 50 μm.
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was investigated mostly in the cephalic region.
Genomically integrated enhancer4-1 recapitulates the endogenous
expression of Sox10 mRNA in developing DRG
We further examined whether the enhancer4-1 activity would also
reﬂect the endogenous expression of Sox10mRNA at later stages of NC-
lineages. Combined with the Tol2-mediated gene transfer technique,
embryos were electroporated with pT2K-enhancer4-1-tkEGFP andpCAGGS-T2TP (Fig. 3A), and their DRGs were compared for EGFP signals
and endogenous Sox10mRNA in alternate sections at different develop-
mental stages. As the expression level of endogenous Sox10mRNAstarted
to decrease at E4 onward (Fig. 3D), the number of EGFP+ cells became
smaller (Fig. 3B, views are obtained with the same exposure time; n=6
for E3, E4, E5, and n=3 for E6 and E7). Co-electroporated control vector,
pT2K-CAGGS-mCherry, remained positive until E7 (Fig. 3C), indicating
that the decline of EGFP signal was not due to a disappearance of the
transgene. The decrease of EGFP signalswas also quantitatively shown by
the ratio of EGFP+ cells over mCherry+ cells in DRG (Fig. 3E). Together,
Fig. 2. Identiﬁcation of NCC-speciﬁc enhancer of the Sox10 gene. (A) Conﬁrmation of NCC-speciﬁc expression of Sox10 mRNA by in situ hybridization and HNK-1 immuno-
histochemical staining in neighboring histological sections. White arrowheads are developing DRGs, and arrows are sympathetic ganglia (scale bar: 100 μm). A square is enlarged
where ﬁlled arrowheads indicated melanocyte precursors migrating underneath the epidermis (scale bar: 20 μm). (B) Comparison of genomic sequences using VISTA between
human and chicken over 43 kb around the chicken Sox10 gene. Conserved sequences where N60 bp homology over 100 bp are shown as sharp peaks. Five non-coding elements
(CNE1–5, red peaks, arrows) were found in the 5′-region of Sox10 ORF, and two UTRs (light blue peaks, arrowheads) in the 3′-region. Conserved sequences within the coding region
are shown as light purple peaks. Eight larger genomic fragments (#1–#8), and 12 dissected fragments (#1-1–#1-7, #4-1–#4-5), were individually inserted into the reporter plasmid
ptkEGFP (C), and assessed for their enhancer activity. Blue boxes are the fragments that showed a NCC-speciﬁc enhancer activity. Gray boxes were the fragments active both in the
neural tube and NCCs. White boxes exhibited no enhancer activity (see also Table 2). (C) ptkEGFP inserted with a genomic fragment was co-electroporated into an E2 neural tube
with pCAGGS-mCherry. (D) Enhancer activities of the fragments of #1-4 (neural tube and NCCs) and #4-1 (NCC). The left three photos are of the same dorsal views of E2.5 embryos.
Arrowheads indicate the neural tube, EGFP+/mCherry+ with enhancer1-4, EGFP−/mCherry+ with enhancer4-1. Small arrows are segmentally formed DRGs, (EGFP+/mCherry+).
Transverse views of these embryos are shown in the right 4 photos. Arrowheads are EGFP signal in the neural tube, and arrows indicate developing DRGs. Again, enhancer4-1 is
speciﬁcally active in DRG. Scale bars: 100 μm. (E) A ratio between EGFP+ cells over mCherry+ cells in the neural tube or DRG is shown. n=12 for each.
386 Y. Yokota et al. / Developmental Biology 353 (2011) 382–395
Table 1
Description of CNEs. Positions in chicken genome, length (bp), and similarity between
human and chicken sequences for each of CNEs (#1–#5) and UTRs (#1–#2) shown in
Fig. 2.
Conserved
noncoding element
Position in chicken
sequence (bp)a
Length in chicken
sequence
Similarity in
human sequence
CNE1 −20,108 to −19,966 146 bp 72.60%
CNE2 −13,012 to −12,887 126 bp 94.40%
CNE3 −8526 to −8348 179 bp 85.50%
CNE4 −7078 to −6977 105 bp 71.40%
CNE5 −4658 to −4527 142 bp 69.50%
UTRl 10,124 to 10,243 120 bp 74.20%
UTR2 11,149 to 11,361 235 bp 68.10%
a The position of the Sox10 translational initiation site is taken as +1 bp.
387Y. Yokota et al. / Developmental Biology 353 (2011) 382–395the activity of enhancer4-1 identiﬁed in this study reﬂects the endogenous
activity of the Sox10 gene in both early and late DRGs.
Tol2-mediated gene transfer combined with Cre/loxP system using
cultured cells
To overcome the inactivation of enhancer4-1 in late NCC lineages,
we combined the above mentioned expression methods with the Cre/
loxP-mediated genetic recombination, the latterwidely used inmouse
genetics. The Cre/loxP system is useful to manipulate a speciﬁc cell
lineage(s) because even a transiently active enhancer-Cre can lead to
persistent expression of a gene (i.e. EGFP) if EGFP is manufactured to
be driven by a constitutive promoter upon the Cre-mediated
recombination (Gu et al., 1994; Hamilton and Abremski, 1984; Lobe
et al., 1999; Nagy, 2000). We therefore combined the enhancer4-1 and
Cre/loxP system along with the Tol2-mediated genomic integration to
achieve a persistent manipulation of late NCC lineages.
We ﬁrst optimized the condition for such combined techniques
using avian cell line DF1 (ﬁbroblast) cultured in vitro. We prepared
three kinds of plasmids (Fig. 4A): pCAGGS-T2TP, pxCANCre(pCAGGS-
Cre), and pT2K-CAGGS-loxP-DsRed2-loxP-EGFP, which contains
DsRed2-stop cassette and EGFP. Without Cre activity, DsRed2 is
constitutively expressed by CAGGS promoter whereas Cre induces an
excision of loxP-DsRed2-loxP (stop cassette), leading to constitutive
EGFP expression driven by CAGGS (Fig. 4A).
We co-transfected these three plasmids into cultured DF1 cells. As
expected, EGFP expression started by 3-day, and lasted until 25-day,Table 2
Details of the genomic fragments used for the enhancer activity assessments (see Fig. 2). Eac
into early neural tube of chicken E2 embryos. NT: EGFP signals seen in neural tube/spinal c
Genomic fragment Position in chicken sequence (bp)a Length in chicken sequenc
1 −24,781 to −16,797 7985 bp
1–1 −24,781 to −19,255 5527 bp
1–2 −24,781 to −22,036 2746 bp
1–3 −24,781 to −23,233 1549 bp
1–4 −24,781 to −23,247 1535 bp
1–5 −24,149 to −23,364 786 bp
1–6 −19,255 to −16,797 2459 bp
1–7 −21,736 to −16,797 4940 bp
2 −24,161 to −15,997 8165 bp
3 −17,947 to −10,223 7725 bp
4 −11,994 to −4,645 7350 bp
4–1 −10,762 to −7,192 3571 bp
4–2 −10,468 to −9426 1043 bp
4–3 −9554 to −8784 771 bp
4–4 −9767 to −9093 675 bp
4–5 −9237 to −7445 1793 bp
5 −7829 to −2204 5626 bp
6 −4161 to 5771 9932 bp
7 157 to 8073 7917 bp
8 7097 to 14,637 7541 bp
a The position of the Sox10 translational initiation site is taken as +1 bp.when the assay was terminated (Fig. 3B, F). Two kinds of control
experiments were performed, lacking either Cre (Fig. 3C) or
transposase (Fig. 3D), respectively. Without Cre, although DsRed2
expression was stably retained, no EGFP-positive cells were observed
(Fig. 3C). Without transposase, although the recombination occurred
successfully displaying EGFP signals, such expression was transient
(Fig. 3D). The data obtained by these control experiments indicate
that the persistent EGFP expression seen in the culture with both
transposase and Cre (Fig. 4B) was a result of genomic integration and
Cre-mediated recombination occurring simultaneously in the cells.
The Cre-mediated recombination of genomically integrated plasmid
in DF1 cells was also quantitatively assessed where the relative number
of EGFP+ cells wasmeasured (EGFP+ cells per 1000 cells). At 4-day post
transfection, the indexwas similar between the culture transfectedwith
the three plasmids (305±14) and the control culture missing
transposase (285±21) (Fig. 4F). However, at 7-day onward, the index
between these two cultures became different: 175±33 with the three
plasmids whereas 99±3 for the control. By 15-day, although almost no
EGFP+ cells were found in the control, 98±15 cells remained EGFP+ in
the culturewith the three plasmids. In the other control that received no
Cre (Fig. 4C), although Tol2-mediated genomic integration occurred
successfully, they were all DsRed2+ and no EGFP signal was found
(Fig. 4C, F). Collectively,we conclude that the threeplasmidsused in this
study enabled Cre-mediated recombination of Tol2-integrated exoge-
nous genes, the ﬁrst demonstration for avian cells.
We further examined whether the recombination of DsRed2-loxP
stop cassette was dose-dependent of pxCANCre. Six different doses of
pxCANCre plasmid were tested (Fig. 4E; 0.1 ng–50 ng). The number of
EGFP+ cells (recombined), DsRed2+ cells (not recombined), and
EGFP- and DsRed2-double positive cells were assessed per 300
transfected cells at 16-day post transfection. EGFP-positive cells
were seen with 5 ng of pxCANCre, with the number becoming greater
as the dose of pxCANCre increased (Fig. 4E). Accordingly, the ratio of
DsRed2+ cells decreased (Fig. 4G). Virtually no double-positive cells
were observed. Thus, the recombination efﬁciency of DsRed2-loxP
stop cassette depends on the dose of Cre protein.
NCC-speciﬁc and persistent expression of transgenes by combining
Sox10-enhancer4-1, Tol2-transposon, and Cre/loxP techniques
We further combined the Cre/loxP system with the NCC-speciﬁc
enhancer to obtain persistent expression of transgenes in NCC-h fragment was inserted into the reporter plasmid ptkEGFP, followed by electroporation
ord. NCC: EGFP signal observed in early NCCs.
e Containing conserved noncoding element Enhancer activity at E2.5 (st. 18)
CNE1 NT, NCC
CNE1 NT, NCC
NT, NCC
NT, NCC
NT, NCC
None
None
CNE1 None
CNE1 NCC
CNE2 None
CNE3, CNE4 NCC
CNE3 NCC
None
None
None
CNE3 None
CNE4, CNE5 None
None
None
UTR1, UTR2 None
Fig. 3. Enhancer4-1 activity reﬂects the expression of endogenous Sox10mRNA. The cassette of enhancer4-1-tkEGFP was subcloned into the Tol2-vector (pT2K-enhancer4-1-tkEGFP).
The three plasmids shown in (A) were co-electroporated into the neural tube/NCCs. (B, C) Same views at each developmental stage. Although the stable integration was successful
revealed by pT2K-CAGGS-mCherry, EGFP signal was diminished at E4 onward. (D) In situ hybridization of Sox10mRNA in neighboring sections of (B, C). Endogenous Sox10mRNA
also diminished in DRG at E4 onward. Scale bars: 75 μm. (E) The decline of EGFP signal in DRG is quantitatively demonstrated. n=10 for each developmental stage.
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pxCANCre was substituted for by pEnhancer4-1-tk-Cre (Fig. 5A). The
three plasmids were co-electroporated into early neural tube/neural
crest at E2 as shown in Fig. 1, and EGFP signals in developing DRG
were examined at E7. As expected, EGFP+ cells were found speciﬁcally
in DRG even though both DRG and spinal cord received transgenes
(DsRed2+) (Fig. 5A; n=15). Two kinds of controls were carried out:
onewith pxCANCre (constitutive Cre activity), and the other with ptk-
Cre (no Cre activity). When co-electroporated with pxCANCre, EGFP
signals were found in both the spinal cord and DRG, showing that the
excision of the DsRed2-stop cassette took place in all the electro-porated cells (n=10, Fig. 5B). When co-electroporated with ptk-Cre,
virtually no EGFP+ cells were observed although DsRed2+ cells were
widely distributed (n=10, Fig. 5C), implying no recombination of the
DsRed2-stop cassette. Together, these data indicate that the com-
pound method using the three plasmids enables NCC-speciﬁc and
persistent expression of transgenes that were stably integrated into
chicken genome.
The NCC-speciﬁc and persistent expression was also observed in
sensory neurons (Fig. 5D; n=7), Schwann cells (Fig. 5E; n=6), and
melanocytes (Fig. 5F; n=6) of E7 embryos in a ﬂat-mounted surface
tissue prepared as shown in Fig. 1.
Fig. 4. Combination of Tol2-mediated genomic integration with Cre/loxP system assessed using cultured DF1 cells. (A) Schematic representation of the principle of the expression
system. The stop cassette (DsRed2) is excised by Cre-activity, leading to constitutive expression of EGFP. (B–D) DF1 cells were co-transfected with pT2K-CAGGS-loxP-DsRed2-loxP-
EGFP (shown on the top) and the plasmids indicated on the left. EGFP+- and DsRed2+ cells were assessed at different time points (n=3 for each). (C, D) Control experiments. Scale
bars: 50 μm. (E) DF1 cells were co-transfected with the same set of plasmids as in (B), with a range of doses of pxCANCre (pCAGGS-Cre), followed by the assessment after 16 days
(n=3 for each). (F) Quantitative representation of EGFP+ cell or DsRed2+ cells in the experiments shown in (B–D). (G) Quantitative representation of EGFP+ cells, DsRed2+ cells, or
EGFP+/DsRed2+ cells in the experiments shown in (E).
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Fig. 5. NCC-speciﬁc and stable expression of electroporated genes in embryos by combining Tol2-Cre/loxP and Sox10 enhancer4-1. The design of experiments is similar to that shown
in Fig. 4, with a substitution of Sox10 enhancer4-1-Cre for CAGGS-Cre, the latter used as a control in this experiment. (A–C) Plasmids were electroporated into a neural tube as shown
in previous ﬁgures, followed by harvesting at E7. Compare a numerous number of EGFP+ cells found in DRG (A) to no EGFP+ cells in (C), showing successful Cre-mediated
recombination. Note also no EGFP+ cells in the spinal cord (A), contrasting with (B), indicating a NCC-speciﬁc transgenesis. Remaining signal of DsRed2 in DRG (A, right) represents
cells where Cre-mediated recombination failed to occur. Cre-activity by CAGGS was stronger than enhancer4-1–Cre since DsRed2+ cells were not observed in (B). n=15 for each.
Scale bars: 100 μm. (D–F) Other types of NCC-derived cells also expressed EGFP stably at E7 of embryos treated as shown in (A); sensory neurons (D), Schwann cells (E), and
melanocytes (F). Flat-mount specimens of surface tissues were prepared from E7 embryos as described in Fig. 1E–G. Scale bars: 50 μm.
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We previously optimized the method of tet-on expression of
transgenes in chickens where electroporated genes can be activated in
a temporally-regulated manner.
(Watanabe et al., 2007). This technique is also applicable to Tol2-
mediated genomically integrated transgenes (Sato et al., 2007). We
therefore extended our study to conditionally manipulate late-
developing NCCs with transgenes in a spacio-temporally speciﬁc
manner. Thus, we combined the tet-on expression method with the
Tol2-integration and Cre/loxP techniques, referred to as Tol2-Cre/
loxP-tet-on method.
Prior to embryonic application, we looked for the optimal condition
using culturedDF1 cells. Four kinds of plasmidswereused, twoofwhich
were as shown in Fig. 4 (pxCANCre and pCAGGS-T2TP). The EGFP-
expression cassette is carried by pT2K-BI-TRE-EGFP (Watanabe et al.,
2007). Brieﬂy, EGFP is under the control of TRE (tetracycline responsive
element), which is activated by rtTA2s-M2 (reverse tet-controlledtranscriptional activator) solely in the presence of doxycycline (Dox;
analog of tetracycline). rtTA2s-M2, subcloned into Tol2-loxP-DsRed2-
containing vector to make pT2K-CAGGS-loxP-DsRed2-loxP-rtTA2s-M2,
(Fig. 6A), would be expressed upon the Cre-mediated excision of the
stop cassette (loxP-DsRed2-loxP). Both the rtTA2s-M2-containing
cassette and EGFP-containing cassette were designed to be integrated
into the genome (in pT2K-vector).
These four plasmids were co-transfected into DF1 cells, and they
were cultured with or without Dox (Fig. 6B, C). Whereas a substantial
number of cells expressed EGFP when added with Dox (Fig. 6B), EGFP
was silent when added with PBS as a control (Fig. 6C). A similar
experiment performedwithDox but lacking Cre yieldedmanyDsRed2+
cells, but no EGFP+ cells (Fig. 6D). Thus, both Cre-mediated excision of
the DsRed2 stop cassette and Dox-dependent activation by rtTA2s-M2
took place simultaneously.
Similarly to Fig. 4F, EGFP expression was persistently retained
at least until 21-day after transfection (Fig. 6E), conﬁrming the Tol2-
mediated genomic integration. However, the relative number of EGFP+
Fig. 6. Tet-on inducible expression combined with Tol2-Cre/loxP system assessed with cultured DF1 cells. This is to add an inducible expression system to the previous expression
method established in Fig. 4. (A) Here, the Cre-mediated recombination leads to the expression of rtTA2s-M2 instead of EGFP. In the presence of Dox, this transactivator is bound to
TRE, activating expression of EGFP that is carried by pT2K-BI-TRE-EGFP. Since both the rtTA2s-M2-containing cassette and TRE-EGFP-containing cassette are genomically integrated
by Tol2, the tet-on manipulation (by injecting Dox solution) is available at late stages of development. (B–D) DF1 cells were co-transfected with three plasmids (top) and those
shown on the left, and assessed for EGFP- and DsRed2 signals at different time points. (C, D) Control experiments. In the presence of Cre and Dox, EGFP was induced to be expressed.
Scale bars: 50 μm. (E) Quantitative representation of EGFP+ cells in the experiments shown in (B–D). (F) Time-course of Dox-induced expression of EGFP. After transfection with the
same set of plasmids shown in (B), three cell lines were established, which expressed EGFP in a Dox-dependent manner. After adding with Dox (0 h), EGFP-positive cells were
counted at different time points. EGFP signal increased at 6 h onward. (G) The increase in EGFP signal observed in (F) was also conﬁrmed by Western blot analyses, with a
quantitative representation.
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in Fig. 4F. In the expression system shown in Fig. 6, two different
plasmids need to be simultaneously integrated into the genome of the
same cell, the incidence occurring at a lower efﬁciency than a single
integration.
We further analyzed a time course of EGFP expression during Dox-
induction. After transfection with the 4 plasmids as shown above, we
obtained three stable DF1 cell lines that expressed EGFP in a Dox-
dependent manner. At 6-h post Dox, cells started to express EGFP, andthe number of EGFP+ cells became greater onward (Fig. 6F). The
increase in EGFP-signal was also conﬁrmed by Western blot analyses
(Fig. 6G). These data show that Dox needs to be administered at least
6 h prior to the TRE-driven activation of genes.
TRE is a bidirectional promoter, which can simultaneously activate
two genes subcloned in opposite directions. Although we solely used
EGFP in this study with the other direction being vacant, any gene to
be tested can be conditionally expressed by Dox administration
together with EGFP.
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manner
Finally, the methods developed above were applied to condition-
ally manipulate late-developing NCC lineages with transgenes in a
spacio-temporally controlled manner. For embryonic NCC manipula-
tion, a similar set of the 4 plasmids was used, but this time Cre
expression was driven by Sox10 enhancer (pEnhancer4-1-tk-Cre)
instead of CAGGS (Fig. 7A). These plasmids were co-electroporatedFig. 7. Combination of tet-on system with Tol2-Cre/loxP and Sox10 enhancer4-1. (A) The
enhancer4-1-Cre for CAGGS-Cre (Fig. 6). (B–F) The four plasmids were electroporated into a
Dox injection, no EGFP-positive cells were found in DRGwhereas DsRed2-positive cells were
was observed after Dox (C, D). No EGFP-positive cells were detected in embryos injected with
derived cells were also Dox-induced to express EGFP; sensory neurons (G), Schwann cells (H
embryos as described in Figs. 1E–G, and 5D–F. n=10 for each. Scale bars: 50 μm.into neural tube/neural crest at E2, followed by Dox injection at E5.
Before the Dox injection, no EGFP+ cells were found in the spinal cord
or DRG, whereas DsRed2 signal waswidely distributed in these tissues
(Fig. 7B, n=16). Following Dox injection, EGFP signals were seen in
DRG at E6 (n=11) and E7 (n=14). Importantly, they were not found
in the spinal cord (Fig. 7C, D). DsRed2+ cells were occasionally seen in
DRG, with the cell number varying between specimens (Fig. 7C, D).
This was probably the case where enhancer4-1-Cre activity was
insufﬁcient to excise the DsRed2 stop cassette. In control embryosdesign of experiments is similar to that shown in Fig. 6, with a substitution of Sox10
neural tube as shown in previous ﬁgures, followed by assessment at E6 and E7. Prior to
seen both in the spinal cord and DRG (B). In contrast, successful induction of EGFP signal
PBS (E, F). Scale bars: 100 μm. (G–I) In E7 embryos as shown in (D), other types of NCC-
), and melanocytes (I). Flat-mount specimens of surface tissues were prepared from E7
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was persistent in both DRG and spinal cord at E6 (n=15, Fig. 7E) and
E7 (n=12, Fig. 7F). Thus, the compound expression system, Tol2-
enhancer4-1-Cre/loxP-tet-on, permits a temporally inducible manip-
ulation with transgenes in NCC-speciﬁc lineages of late developing
embryos. This was also evident in sensory neurons, Schwann cells,
andmelanocytes in E7 embryos (Fig. 7G–I, n=3 for each), observed in
a ﬂat-mount specimen.
The compound methods allowed ex vivo direct visualization of individual
Schwann cells associated with peripheral axon bundles
To prove that the methods described above were indeed powerful
to gain mechanistic insights into late development of NCCs in vivo, we
focused on cellular activity of Schwann cells associated with axons in
peripheral tissues. In particular, we exploited the advantage of the
methods permitting analyses at a single cell resolution in three-
dimensional environment/in vivo. For this purpose, we used the
method described in Fig. 5, the combination of Sox10-enhancer4-1,
Tol2-transposon, and Cre/loxP. In the course of aforementioned
experiments, we had noticed that the activity of Sox10-enhancer4-1
was not sufﬁcient to achieve a complete excision of loxP-DsRed2-loxP
(stop cassette), thus leading to mosaic labeling of NCC-derived cellsFig. 8. Time-lapse live-imaging confocal microscopy to simultaneously visualize EGFP-labele
developmental stages were shown (A) E3.5, (B) E4.5, and (C) E7. In all specimens, ex vivo cu
Cre, and pT2K-CAGGS-loxP-DsRed2-loxP-EGFP were co-electroporated. Views containing
neurons were live-imaged using a 40× Plan-Apochromat objective lens. The photos are part
extension and retraction of lamellipodia and ﬁlopodia-like processes, which were protruded
structures parallel to the axons, and occasionally extended a process traversing several axo
positive sensory neurons. The cells were profoundly elongated and static with little cellular p
(right). Scale bars: 20 μm.with EGFP (recombined by Cre) or DsRed2 (not recombined by Cre)
(Fig. 5A, Fig. 7C, D). We therefore exploited such idleness of
enhancer4-1 to obtain Schwann cells and peripheral axons that were
simultaneously labeled with different ﬂuorescents; stochastically, a
EGFP-labeled Schwann cell was found near DsRed2-positive axon(s),
or vice versa. Electroporated embryos were cut into slices, and a slice
that contained differently colored Schwann cell(s) and axon(s) was
subjected to confocal time-lapse microscopy. We paid attention to
sensory neurons, which were efﬁciently and reproducibly labeled
with either DsRed2 or EGFP (see above).
At E3.5, when a majority of Schwann cells were found near
extending axon bundles, these cells were amorphic, and exhibited
active cellular processes, including lamellipodia and ﬁlopodia, that
repeatedly extended and retracted. These processes were randomly
directed (n=5, Fig. 8A, Movie 1). At E4.5, the behavior of labeled
Schwann cells was largely similar to that seen at E3.5. Several cells
were prone to be closely attached to axons. Occasionally, cellular
processes were seen traversing several axons (n=7, Fig. 8B, Movie 2).
At E7, in clear contrast, Schwann cells were profoundly elongatedwith
a thin cell bodywith a tight associationwith axons bundles. These cells
were static with little cellular processes (n=6, Fig. 8C, Movie 3).
Until present, all the studies reporting behaviors of Schwann cells
along axons were performed in vitro using cultured cells, whered Schwann cell(s) and DsRed2-labeled sensory axons in the same view. Three different
ltured slices were prepared from embryos into which pCAGGS-T2TP, pEnhancer4-1-tk-
EGFP-positive Schwann cell(s) associated with DsRed2-positive axon(s) of sensory
of the movies 1–3 (Supplementary materials). (A) E3.5 Schwann cells exhibited active
to random direction. (B) E4.5 EGFP-positive Schwann cells often showed ﬁlopodia-like
ns (arrows). (C) E7 EGFP-positive Schwann cells were closely associated with DsRed2-
rocesses. Location and orientation of the recorded specimens are as shown in a diagram
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signiﬁcantly different from in vivo (Yu et al., 2009).
In those studies, although some ﬁlopodia-like protrusions by naïve
Schwann cells were observed, the cease of such activities and the time
course of cell elongation were unattended. It is conceivable by our
ﬁndings that in normal environment, naïve Schwann cells actively
show cellular protrusions as amorphic cells, and as the cells become
mature, they increasingly ﬁll the surface of nearby axons with a tight
association between them, resulting in the cease of protrusion of
cellular processes. Further studies are awaited to unveil how these
changes in cell behavior are regulated. Together, the ex vivo
visualization of Schwann cells at a single cell level, allowed for the
ﬁrst time by virtue of the method described in this study, provides
new insights into the association of developing Schwann cells with
nearby axons in vivo. Our ﬁndings also underscore the importance of
NCC studies of in the actual body.
Conclusion
In this study we have developed compound methods with which
transgenes are persistently or conditionally manipulated in NCC-
derived lineages of late developing embryos (Fig. 9). The usefulness of
these methods has subsequently been proved by a direct and
simultaneous visualization of EGFP-labeled Schwann cells and
DsRed2-labeled axons in three dimensional environment. ThisFig. 9. Schematic demonstration of the summary of this study. Early, middle, and late stages
derivatives are shown. Motor neurons, non-NCC-origin, are also EGFP-labeled unless NCC-en
but stable (A), NCC-speciﬁc but not persistent (B), NCC-speciﬁc and persistent (C), and NCC-
See text for detailed explanation. MN: motor neurons, M: melanocytes, Scw: Schwann cellsunprecedented approach has provided novel aspects of cellular
behavior and activities of Schwann cells when they are associated
with axon bundle structures in peripheral tissues.
Four types of compound methods have been developed. First, the
Tol2-mediated genomic integration method has enabled persistent
expression of electroporated genes in cells including NCC-derived
lineages (Fig. 9A). This persistent expression is particularly valuable
because unlike central nervous system the NCCs are highly
proliferative and therefore non-integrated genes disappear rapidly.
Second, a combination of the Tol2-method with the NCC-enhancer
(enhancer4-1), identiﬁed in this study, drives NCC-speciﬁc expression
of transgenes. This is useful particularly when sensory neurons or
Schwann cells (NCC-derived) need to be manipulated separately
from closely related tissues, i.e. motor neurons (Fig. 9B). Third, Cre/
loxP-mediated DNA recombination further adds advantages that
NCC-derived cells are speciﬁcally and persistently manipulated
regardless of a declined activity of Sox10 enhancer at later stages
(Fig. 9C). Fourth,wehave further combined thesemethodswith the tet-
on expression technique by which expression of transgenes can be
induced at a desired timepoint duringNCCdifferentiation (Fig. 9D). This
permits conditional manipulation of late-developing NCC lineages with
exogenous genes. Last, by exploiting these methods, we have, for the
ﬁrst time, succeeded in direct visualization of axon-associated Schwann
cells at a single cell level in vivo/ex vivo. They show previously
unappreciated behaviors, which depend on developmental stages. Ourof electroporated embryos are represented, where early NCCs and late developing NCC-
hancer is used (A). Increasingly compound methods (from A to D) permit non-speciﬁc
speciﬁc, persistent, and temporally controlled manipulations (D) with exogenous genes.
.
395Y. Yokota et al. / Developmental Biology 353 (2011) 382–395study has opened a novel way to investigate at molecular and cellular
levels how the lateNCCdevelopment is regulated, the long-standingbut
yet unsolved question. The principles described in this studywill also be
applicable to other embryonic cell lineages where tissue-speciﬁc
enhancers are available.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.02.001.
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